This paper is in the following e-collection/theme issue:

COVID-19 Vaccination (140) JMIR Theme Issue: COVID-19 Special Issue (2439) Infectious Diseases (non-STD/STI) (1555) Outbreak and Pandemic Preparedness and Management (1714) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1513) Vaccination and Immunization in the Digital Age (365) Hygiene and Infection Prevention (310)

Published on in Vol 8, No 11 (2022): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/38898, first published .
The Risk of Hospitalization and Mortality After Breakthrough SARS-CoV-2 Infection by Vaccine Type: Observational Study of Medical Claims Data

The Risk of Hospitalization and Mortality After Breakthrough SARS-CoV-2 Infection by Vaccine Type: Observational Study of Medical Claims Data

The Risk of Hospitalization and Mortality After Breakthrough SARS-CoV-2 Infection by Vaccine Type: Observational Study of Medical Claims Data

Authors of this article:

Meghana Kshirsagar1 Author Orcid Image ;   Md Nasir1 Author Orcid Image ;   Sumit Mukherjee2 Author Orcid Image ;   Nicholas Becker1, 3 Author Orcid Image ;   Rahul Dodhia1 Author Orcid Image ;   William B Weeks1 Author Orcid Image ;   Juan Lavista Ferres1 Author Orcid Image ;   Barbra Richardson4 Author Orcid Image
Article Authors Cited by (5) Tweetations (6) Metrics

Journals

  1. Fogolari M, Francesconi M, De Florio L, Giovanetti M, Veralli R, De Flora C, Maruotti A, Scarpa F, Spoto S, Sambuco F, Riva E, Ciccozzi M, Angeletti S. SARS-CoV-2 Variants in COVID-19 Disease: A Focus on Disease Severity and Vaccine Immunity in Patients Admitted to the Emergency Department. Journal of Personalized Medicine 2022;12(12):2001 View
  2. Chi H, Chiu N, Chen C, Weng S, Lien C, Lin C, Hu Y, Lei W, Tai Y, Lin L, Liu L, Lin C. To PCR or not? The impact of shifting policy from PCR to rapid antigen tests to diagnose COVID-19 during the omicron epidemic: a nationwide surveillance study. Frontiers in Public Health 2023;11 View
  3. Ruggieri S, Aiello A, Tortorella C, Navarra A, Vanini V, Meschi S, Lapa D, Haggiag S, Prosperini L, Cuzzi G, Salmi A, Quartuccio M, Altera A, Garbuglia A, Ascoli Bartoli T, Galgani S, Notari S, Agrati C, Puro V, Nicastri E, Gasperini C, Goletti D. Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose. International Journal of Molecular Sciences 2023;24(10):8525 View
  4. Pérez-Tasigchana F, Valcárcel-Pérez I, Arias-Quispe M, Astudillo L, Bruno A, Herrera G. M, Armas R, de Mora D, Pinos J, Olmedo A, Salas R, Jimbo-Sotomayor R, Chiluisa C, Acosta P, Sánchez X, Whittembury A. Effectiveness of COVID-19 vaccines in Ecuador: A test-negative design. Vaccine: X 2023;15:100404 View
  5. Melillo A, Perrottelli A, Caporusso E, Coltorti A, Giordano G, Giuliani L, Pezzella P, Bucci P, Mucci A, Galderisi S, Maj M. Research evidence on the management of the cognitive impairment component of the post-COVID condition: a qualitative systematic review. European Psychiatry 2024;67(1) View